Christopher Litterio Sells 1,829 Shares of UFP Technologies (NASDAQ:UFPT) Stock

UFP Technologies, Inc. (NASDAQ:UFPT) SVP Christopher Litterio sold 1,829 shares of UFP Technologies stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $227.20, for a total transaction of $415,548.80. Following the completion of the transaction, the senior vice president owned 10,756 shares of the company’s stock, valued at $2,443,763.20. This trade represents a 14.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

UFP Technologies Trading Up 0.6%

UFP Technologies stock traded up $1.38 during mid-day trading on Wednesday, hitting $246.98. The stock had a trading volume of 46,937 shares, compared to its average volume of 131,935. The stock has a 50-day simple moving average of $202.28 and a two-hundred day simple moving average of $221.16. The company has a current ratio of 2.77, a quick ratio of 1.53 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $1.90 billion, a PE ratio of 28.62 and a beta of 1.16. UFP Technologies, Inc. has a 12 month low of $178.26 and a 12 month high of $349.77.

UFP Technologies (NASDAQ:UFPT) last issued its earnings results on Thursday, November 9th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter. The company had revenue of $96.97 million for the quarter. UFP Technologies had a net margin of 11.40% and a return on equity of 21.54%.

Analyst Ratings Changes

Several research analysts have recently issued reports on UFPT shares. Lake Street Capital raised their price target on UFP Technologies from $252.00 to $289.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Weiss Ratings restated a “hold (c)” rating on shares of UFP Technologies in a report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $289.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Principal Financial Group Inc. increased its holdings in UFP Technologies by 3.0% in the 1st quarter. Principal Financial Group Inc. now owns 40,274 shares of the industrial products company’s stock valued at $8,124,000 after buying an additional 1,166 shares during the period. Envestnet Asset Management Inc. lifted its holdings in shares of UFP Technologies by 261.3% in the first quarter. Envestnet Asset Management Inc. now owns 75,194 shares of the industrial products company’s stock worth $15,167,000 after acquiring an additional 54,382 shares during the last quarter. New York State Common Retirement Fund grew its holdings in shares of UFP Technologies by 37.2% during the 1st quarter. New York State Common Retirement Fund now owns 93,997 shares of the industrial products company’s stock valued at $18,960,000 after purchasing an additional 25,497 shares during the last quarter. Dakota Wealth Management acquired a new position in UFP Technologies during the 1st quarter worth approximately $204,000. Finally, Massachusetts Financial Services Co. MA boosted its position in UFP Technologies by 28.0% in the first quarter. Massachusetts Financial Services Co. MA now owns 132,571 shares of the industrial products company’s stock valued at $26,741,000 after buying an additional 28,997 shares in the last quarter. 87.28% of the stock is owned by institutional investors and hedge funds.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.